Analgesics⏵
Antiandrogens⏵
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle⏵
Melatonin
Metformin
Minerals⏵
Molnupiravir
Monoclonals⏵
Naso/orophar..⏵
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins⏵
More⏵

Other
Feedback
Home
Top
Results
All zinc studies
Meta analysis
 
Feedback
Home
←
next
study
→
previous
study
c19early.org COVID-19 treatment researchZincZinc (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta
Home Adoption Other Treatments
@CovidAnalysis
All Studies   Meta Analysis    Recent:   

Relationship of serum zinc levels with severity and clinical presentation of COVID-19

Haji et al., Infectious Diseases, 22:2
Jun 2022  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Hospitalization 66% Improvement Relative Risk Zinc for COVID-19  Haji et al.  Sufficiency Are zinc levels associated with COVID-19 outcomes? Retrospective 150 patients in Iraq Lower hospitalization with higher zinc levels (p=0.000026) c19early.org Haji et al., Infectious Diseases, June 2022 Favorszinc Favorscontrol 0 0.5 1 1.5 2+
Zinc for COVID-19
2nd treatment shown to reduce risk in July 2020
 
*, now with p = 0.00000064 from 45 studies, recognized in 17 countries.
Lower risk for mortality, ventilation, hospitalization, progression, recovery, and viral clearance.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,700+ studies for 95 treatments. c19early.org
Prospective study of 150 COVID-19 patients and 50 healthy controls in Iraq showing lower serum zinc levels associated with more severe COVID-19 outcomes. Patients with zinc deficiency (<0.7 mg/L) had longer recovery periods and higher rates of hospitalization compared to those with sufficient or high zinc levels. 40% of COVID-19 patients were zinc deficient.
Important missing comments or errors? Let us know.
risk of hospitalization, 65.6% lower, RR 0.34, p < 0.001, high zinc levels (≥0.7mg/L) 16 of 90 (17.8%), low zinc levels (<0.7mg/L) 31 of 60 (51.7%), NNT 3.0.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Haji et al., 28 Jun 2022, retrospective, Iraq, peer-reviewed, 2 authors.
This PaperZincAll
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit    
Post
Share
@CovidAnalysis
FAQ
Public domain CC0 1.0